About Our Lady of Mercy Medical Center
Clinical Trials at Our Lady of Mercy Medical Center
During the past decade, Our Lady of Mercy Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Our Lady of Mercy Medical Center" #1 sponsor was "CTI BioPharma" with 3 trials, followed by "Favrille" with 2 trials
sponsored, "Amgen" with 1 trials sponsored, "Biogen" with 1 trials sponsored and "Genentech, Inc."
with 1 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Our Lady of Mercy Medical Center"
#1 collaborator was "Cancer and Leukemia Group B" with 1 trials as a collaborator, "Chiron Corporation" with 1 trials as a collaborator, "North Central Cancer Treatment Group" with 1 trials as a collaborator and "SWOG Cancer Research Network" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Our Lady of Mercy Medical Center
According to Clinical.Site data, the most researched conditions in "Our Lady of Mercy Medical Center" are
"Leukemia" (2 trials), "Lymphoma" (2 trials), "Non-Hodgkin's Lymphoma" (2 trials), "Breast Cancer" (1 trials) and "Diffuse Large-Cell Lymphoma" (1 trials). Many other conditions were trialed in "Our Lady of Mercy Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Our Lady of Mercy Medical Center
Most popular intervention types in "Our Lady of Mercy Medical Center" are "Drug" (11 trials) and "Biological" (5 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (2 trials), "doxorubicin hydrochloride" (2 trials), "filgrastim" (2 trials), "paclitaxel" (2 trials) and "rituximab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Our Lady of Mercy Medical Center
The vast majority of trials in "Our Lady of Mercy Medical Center" are
10 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Our Lady of Mercy Medical Center
Currently, there are NaN active trials in "Our Lady of Mercy Medical Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Our Lady of Mercy Medical Center,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Our Lady of Mercy Medical Center, 0 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".